nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR2A—phrenic nerve—thymus cancer	0.0426	0.126	CbGeAlD
Imipramine—KCND3—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0319	0.233	CbGpPWpGaD
Imipramine—KCND2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0285	0.208	CbGpPWpGaD
Imipramine—HTR7—pulmonary artery—thymus cancer	0.0248	0.0734	CbGeAlD
Imipramine—HTR7—vein—thymus cancer	0.0226	0.0668	CbGeAlD
Imipramine—Galactorrhoea—Octreotide—thymus cancer	0.0212	0.0404	CcSEcCtD
Imipramine—Abdominal cramps—Octreotide—thymus cancer	0.0204	0.0388	CcSEcCtD
Imipramine—Tingling sensation—Octreotide—thymus cancer	0.0171	0.0326	CcSEcCtD
Imipramine—Petechiae—Octreotide—thymus cancer	0.0167	0.0318	CcSEcCtD
Imipramine—Numbness—Octreotide—thymus cancer	0.0166	0.0316	CcSEcCtD
Imipramine—Endocrine disorder—Octreotide—thymus cancer	0.0166	0.0316	CcSEcCtD
Imipramine—KCND3—Potassium Channels—KCNA4—thymus cancer	0.0164	0.12	CbGpPWpGaD
Imipramine—Sensory loss—Octreotide—thymus cancer	0.0159	0.0302	CcSEcCtD
Imipramine—HTR2A—pulmonary artery—thymus cancer	0.0155	0.0458	CbGeAlD
Imipramine—KCND2—Potassium Channels—KCNA4—thymus cancer	0.0146	0.107	CbGpPWpGaD
Imipramine—HTR2A—vein—thymus cancer	0.0141	0.0417	CbGeAlD
Imipramine—Gynaecomastia—Octreotide—thymus cancer	0.0123	0.0234	CcSEcCtD
Imipramine—Sleep disorder—Octreotide—thymus cancer	0.0115	0.022	CcSEcCtD
Imipramine—Cardiac failure congestive—Octreotide—thymus cancer	0.011	0.021	CcSEcCtD
Imipramine—Hot flush—Octreotide—thymus cancer	0.0107	0.0203	CcSEcCtD
Imipramine—Menopausal symptoms—Octreotide—thymus cancer	0.0106	0.0202	CcSEcCtD
Imipramine—KCNH2—Voltage gated Potassium channels—KCNA4—thymus cancer	0.0105	0.0769	CbGpPWpGaD
Imipramine—Psychotic disorder—Octreotide—thymus cancer	0.00975	0.0186	CcSEcCtD
Imipramine—KCND2—pituitary gland—thymus cancer	0.0082	0.0242	CbGeAlD
Imipramine—Pollakiuria—Octreotide—thymus cancer	0.00797	0.0152	CcSEcCtD
Imipramine—Weight increased—Octreotide—thymus cancer	0.00785	0.015	CcSEcCtD
Imipramine—Weight decreased—Octreotide—thymus cancer	0.0078	0.0149	CcSEcCtD
Imipramine—Drowsiness—Octreotide—thymus cancer	0.00769	0.0147	CcSEcCtD
Imipramine—Neuropathy peripheral—Octreotide—thymus cancer	0.00754	0.0144	CcSEcCtD
Imipramine—Jaundice—Octreotide—thymus cancer	0.0075	0.0143	CcSEcCtD
Imipramine—KCND3—cardiac atrium—thymus cancer	0.00731	0.0216	CbGeAlD
Imipramine—Hepatobiliary disease—Octreotide—thymus cancer	0.00727	0.0139	CcSEcCtD
Imipramine—KCND3—Neuronal System—KCNA4—thymus cancer	0.00715	0.0522	CbGpPWpGaD
Imipramine—Hepatitis—Octreotide—thymus cancer	0.00691	0.0132	CcSEcCtD
Imipramine—Hypoaesthesia—Octreotide—thymus cancer	0.00687	0.0131	CcSEcCtD
Imipramine—SLC22A4—neck—thymus cancer	0.00682	0.0202	CbGeAlD
Imipramine—CHRM5—epithelium—thymus cancer	0.00656	0.0194	CbGeAlD
Imipramine—Tinnitus—Octreotide—thymus cancer	0.00644	0.0123	CcSEcCtD
Imipramine—Cardiac disorder—Octreotide—thymus cancer	0.00641	0.0122	CcSEcCtD
Imipramine—Flushing—Octreotide—thymus cancer	0.00641	0.0122	CcSEcCtD
Imipramine—KCND2—Neuronal System—KCNA4—thymus cancer	0.00638	0.0465	CbGpPWpGaD
Imipramine—Immune system disorder—Octreotide—thymus cancer	0.00624	0.0119	CcSEcCtD
Imipramine—Arrhythmia—Octreotide—thymus cancer	0.00617	0.0118	CcSEcCtD
Imipramine—KCND3—thyroid gland—thymus cancer	0.00616	0.0182	CbGeAlD
Imipramine—Alopecia—Octreotide—thymus cancer	0.0061	0.0116	CcSEcCtD
Imipramine—Mental disorder—Octreotide—thymus cancer	0.00605	0.0115	CcSEcCtD
Imipramine—Malnutrition—Octreotide—thymus cancer	0.00601	0.0115	CcSEcCtD
Imipramine—Tension—Octreotide—thymus cancer	0.0059	0.0112	CcSEcCtD
Imipramine—ADRA1D—epithelium—thymus cancer	0.00586	0.0173	CbGeAlD
Imipramine—Nervousness—Octreotide—thymus cancer	0.00584	0.0111	CcSEcCtD
Imipramine—Vision blurred—Octreotide—thymus cancer	0.00566	0.0108	CcSEcCtD
Imipramine—Tremor—Octreotide—thymus cancer	0.00563	0.0107	CcSEcCtD
Imipramine—KCND3—lung—thymus cancer	0.00559	0.0165	CbGeAlD
Imipramine—Ill-defined disorder—Octreotide—thymus cancer	0.00558	0.0106	CcSEcCtD
Imipramine—Agitation—Octreotide—thymus cancer	0.00552	0.0105	CcSEcCtD
Imipramine—Malaise—Octreotide—thymus cancer	0.00542	0.0103	CcSEcCtD
Imipramine—KCNH2—Potassium Channels—KCNA4—thymus cancer	0.00541	0.0394	CbGpPWpGaD
Imipramine—Syncope—Octreotide—thymus cancer	0.00539	0.0103	CcSEcCtD
Imipramine—Palpitations—Octreotide—thymus cancer	0.00531	0.0101	CcSEcCtD
Imipramine—Loss of consciousness—Octreotide—thymus cancer	0.00528	0.0101	CcSEcCtD
Imipramine—ORM1—hematopoietic system—thymus cancer	0.00528	0.0156	CbGeAlD
Imipramine—Convulsion—Octreotide—thymus cancer	0.00521	0.00992	CcSEcCtD
Imipramine—Hypertension—Octreotide—thymus cancer	0.00519	0.00989	CcSEcCtD
Imipramine—HTR7—neck—thymus cancer	0.00513	0.0152	CbGeAlD
Imipramine—Anxiety—Octreotide—thymus cancer	0.0051	0.00972	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00508	0.00968	CcSEcCtD
Imipramine—Discomfort—Octreotide—thymus cancer	0.00506	0.00963	CcSEcCtD
Imipramine—Dry mouth—Octreotide—thymus cancer	0.005	0.00954	CcSEcCtD
Imipramine—SLC6A3—hematopoietic system—thymus cancer	0.00491	0.0145	CbGeAlD
Imipramine—Anaphylactic shock—Octreotide—thymus cancer	0.00491	0.00935	CcSEcCtD
Imipramine—Oedema—Octreotide—thymus cancer	0.00491	0.00935	CcSEcCtD
Imipramine—Infection—Octreotide—thymus cancer	0.00487	0.00929	CcSEcCtD
Imipramine—Shock—Octreotide—thymus cancer	0.00483	0.0092	CcSEcCtD
Imipramine—Nervous system disorder—Octreotide—thymus cancer	0.00481	0.00917	CcSEcCtD
Imipramine—Thrombocytopenia—Octreotide—thymus cancer	0.0048	0.00915	CcSEcCtD
Imipramine—Tachycardia—Octreotide—thymus cancer	0.00479	0.00912	CcSEcCtD
Imipramine—Skin disorder—Octreotide—thymus cancer	0.00477	0.00908	CcSEcCtD
Imipramine—Hyperhidrosis—Octreotide—thymus cancer	0.00474	0.00904	CcSEcCtD
Imipramine—Anorexia—Octreotide—thymus cancer	0.00468	0.00891	CcSEcCtD
Imipramine—SLC22A3—hematopoietic system—thymus cancer	0.00462	0.0137	CbGeAlD
Imipramine—SLC6A4—hematopoietic system—thymus cancer	0.0045	0.0133	CbGeAlD
Imipramine—Insomnia—Octreotide—thymus cancer	0.00444	0.00845	CcSEcCtD
Imipramine—Paraesthesia—Octreotide—thymus cancer	0.00441	0.00839	CcSEcCtD
Imipramine—Somnolence—Octreotide—thymus cancer	0.00436	0.00831	CcSEcCtD
Imipramine—Dyspepsia—Octreotide—thymus cancer	0.00432	0.00823	CcSEcCtD
Imipramine—Decreased appetite—Octreotide—thymus cancer	0.00426	0.00813	CcSEcCtD
Imipramine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00424	0.00807	CcSEcCtD
Imipramine—Fatigue—Octreotide—thymus cancer	0.00423	0.00806	CcSEcCtD
Imipramine—Constipation—Octreotide—thymus cancer	0.0042	0.00799	CcSEcCtD
Imipramine—Feeling abnormal—Octreotide—thymus cancer	0.00404	0.0077	CcSEcCtD
Imipramine—Gastrointestinal pain—Octreotide—thymus cancer	0.00401	0.00764	CcSEcCtD
Imipramine—HTR1A—hematopoietic system—thymus cancer	0.00399	0.0118	CbGeAlD
Imipramine—Urticaria—Octreotide—thymus cancer	0.0039	0.00743	CcSEcCtD
Imipramine—Abdominal pain—Octreotide—thymus cancer	0.00388	0.00739	CcSEcCtD
Imipramine—Body temperature increased—Octreotide—thymus cancer	0.00388	0.00739	CcSEcCtD
Imipramine—KCND3—lymph node—thymus cancer	0.00383	0.0113	CbGeAlD
Imipramine—HTR7—hematopoietic system—thymus cancer	0.00382	0.0113	CbGeAlD
Imipramine—SLC22A4—pituitary gland—thymus cancer	0.00377	0.0111	CbGeAlD
Imipramine—CYP2C19—hematopoietic system—thymus cancer	0.00373	0.011	CbGeAlD
Imipramine—ADRA1A—hematopoietic system—thymus cancer	0.00368	0.0109	CbGeAlD
Imipramine—KCNH2—hematopoietic system—thymus cancer	0.00356	0.0105	CbGeAlD
Imipramine—Asthenia—Octreotide—thymus cancer	0.00352	0.00671	CcSEcCtD
Imipramine—HTR7—epithelium—thymus cancer	0.00349	0.0103	CbGeAlD
Imipramine—Pruritus—Octreotide—thymus cancer	0.00347	0.00661	CcSEcCtD
Imipramine—ORM1—bone marrow—thymus cancer	0.00338	0.01	CbGeAlD
Imipramine—ADRA1A—epithelium—thymus cancer	0.00337	0.00995	CbGeAlD
Imipramine—Diarrhoea—Octreotide—thymus cancer	0.00336	0.0064	CcSEcCtD
Imipramine—SLC22A4—bone marrow—thymus cancer	0.00326	0.00963	CbGeAlD
Imipramine—SLC22A4—thyroid gland—thymus cancer	0.00325	0.0096	CbGeAlD
Imipramine—Dizziness—Octreotide—thymus cancer	0.00324	0.00618	CcSEcCtD
Imipramine—HTR2A—neck—thymus cancer	0.0032	0.00946	CbGeAlD
Imipramine—Vomiting—Octreotide—thymus cancer	0.00312	0.00594	CcSEcCtD
Imipramine—Rash—Octreotide—thymus cancer	0.00309	0.00589	CcSEcCtD
Imipramine—Dermatitis—Octreotide—thymus cancer	0.00309	0.00589	CcSEcCtD
Imipramine—Headache—Octreotide—thymus cancer	0.00307	0.00586	CcSEcCtD
Imipramine—ORM1—lung—thymus cancer	0.00307	0.00907	CbGeAlD
Imipramine—CYP1A2—hematopoietic system—thymus cancer	0.00304	0.009	CbGeAlD
Imipramine—SLC22A3—thyroid gland—thymus cancer	0.00296	0.00874	CbGeAlD
Imipramine—SLC22A4—lung—thymus cancer	0.00295	0.00872	CbGeAlD
Imipramine—CYP2B6—hematopoietic system—thymus cancer	0.00292	0.00863	CbGeAlD
Imipramine—Nausea—Octreotide—thymus cancer	0.00291	0.00555	CcSEcCtD
Imipramine—SLC6A3—lung—thymus cancer	0.00285	0.00843	CbGeAlD
Imipramine—HRH1—hematopoietic system—thymus cancer	0.00285	0.00843	CbGeAlD
Imipramine—CYP2E1—hematopoietic system—thymus cancer	0.00274	0.0081	CbGeAlD
Imipramine—KCNH2—cardiac atrium—thymus cancer	0.0027	0.00799	CbGeAlD
Imipramine—SLC22A3—lung—thymus cancer	0.00268	0.00794	CbGeAlD
Imipramine—DRD2—pituitary gland—thymus cancer	0.00268	0.00792	CbGeAlD
Imipramine—KCNH2—pituitary gland—thymus cancer	0.00264	0.0078	CbGeAlD
Imipramine—SLC6A4—lung—thymus cancer	0.00261	0.00773	CbGeAlD
Imipramine—HRH1—epithelium—thymus cancer	0.00261	0.0077	CbGeAlD
Imipramine—CHRM1—lung—thymus cancer	0.0026	0.0077	CbGeAlD
Imipramine—ADRA1A—lymphoid tissue—thymus cancer	0.00259	0.00767	CbGeAlD
Imipramine—CHRM3—thyroid gland—thymus cancer	0.00256	0.00758	CbGeAlD
Imipramine—HTR2A—hematopoietic system—thymus cancer	0.00238	0.00704	CbGeAlD
Imipramine—KCNH2—Neuronal System—KCNA4—thymus cancer	0.00236	0.0172	CbGpPWpGaD
Imipramine—SLC6A2—lung—thymus cancer	0.0023	0.0068	CbGeAlD
Imipramine—KCNH2—bone marrow—thymus cancer	0.00228	0.00674	CbGeAlD
Imipramine—HTR7—lung—thymus cancer	0.00222	0.00656	CbGeAlD
Imipramine—CYP3A4—hematopoietic system—thymus cancer	0.0022	0.00652	CbGeAlD
Imipramine—HTR2A—epithelium—thymus cancer	0.00218	0.00643	CbGeAlD
Imipramine—CYP2D6—hematopoietic system—thymus cancer	0.00217	0.00641	CbGeAlD
Imipramine—ORM1—lymph node—thymus cancer	0.0021	0.0062	CbGeAlD
Imipramine—DRD2—lung—thymus cancer	0.0021	0.0062	CbGeAlD
Imipramine—CYP2B6—lymphoid tissue—thymus cancer	0.00205	0.00608	CbGeAlD
Imipramine—SLC22A4—lymph node—thymus cancer	0.00202	0.00597	CbGeAlD
Imipramine—CYP1A2—thyroid gland—thymus cancer	0.00195	0.00576	CbGeAlD
Imipramine—CYP2E1—lymphoid tissue—thymus cancer	0.00193	0.0057	CbGeAlD
Imipramine—SLC22A3—lymph node—thymus cancer	0.00184	0.00543	CbGeAlD
Imipramine—CYP1A2—lung—thymus cancer	0.00177	0.00523	CbGeAlD
Imipramine—HTR2A—pituitary gland—thymus cancer	0.00177	0.00522	CbGeAlD
Imipramine—CYP2E1—thyroid gland—thymus cancer	0.00175	0.00518	CbGeAlD
Imipramine—CYP2B6—lung—thymus cancer	0.0017	0.00501	CbGeAlD
Imipramine—HRH1—lung—thymus cancer	0.00166	0.0049	CbGeAlD
Imipramine—SLC6A3—Neuronal System—KCNA4—thymus cancer	0.00162	0.0118	CbGpPWpGaD
Imipramine—CYP2E1—lung—thymus cancer	0.00159	0.0047	CbGeAlD
Imipramine—SLC6A2—lymph node—thymus cancer	0.00157	0.00465	CbGeAlD
Imipramine—ABCB1—hematopoietic system—thymus cancer	0.00156	0.00461	CbGeAlD
Imipramine—SLC22A2—Neuronal System—KCNA4—thymus cancer	0.00147	0.0107	CbGpPWpGaD
Imipramine—ABCB1—epithelium—thymus cancer	0.00143	0.00422	CbGeAlD
Imipramine—KCNH2—lymph node—thymus cancer	0.00141	0.00418	CbGeAlD
Imipramine—HTR2A—lung—thymus cancer	0.00138	0.00409	CbGeAlD
Imipramine—SLC22A1—Neuronal System—KCNA4—thymus cancer	0.00137	0.01	CbGpPWpGaD
Imipramine—ABCB1—pituitary gland—thymus cancer	0.00116	0.00342	CbGeAlD
Imipramine—HRH1—lymph node—thymus cancer	0.00113	0.00335	CbGeAlD
Imipramine—ABCB1—lymphoid tissue—thymus cancer	0.0011	0.00325	CbGeAlD
Imipramine—ABCB1—bone marrow—thymus cancer	0.001	0.00296	CbGeAlD
Imipramine—ABCB1—thyroid gland—thymus cancer	0.000998	0.00295	CbGeAlD
Imipramine—ABCB1—lung—thymus cancer	0.000906	0.00268	CbGeAlD
Imipramine—ABCB1—lymph node—thymus cancer	0.00062	0.00183	CbGeAlD
Imipramine—KCND2—Circadian rythm related genes—TP53—thymus cancer	0.000508	0.00371	CbGpPWpGaD
Imipramine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.000439	0.0032	CbGpPWpGaD
Imipramine—ADRA1B—AMPK Signaling—TP53—thymus cancer	0.000264	0.00193	CbGpPWpGaD
Imipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000259	0.00189	CbGpPWpGaD
Imipramine—HRH1—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000246	0.00179	CbGpPWpGaD
Imipramine—ADRA1B—LPA receptor mediated events—AKT1—thymus cancer	0.000237	0.00173	CbGpPWpGaD
Imipramine—ADRA1A—AMPK Signaling—TP53—thymus cancer	0.000235	0.00171	CbGpPWpGaD
Imipramine—ADRA1B—AMPK Signaling—AKT1—thymus cancer	0.000223	0.00163	CbGpPWpGaD
Imipramine—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000211	0.00154	CbGpPWpGaD
Imipramine—ADRA1A—AMPK Signaling—AKT1—thymus cancer	0.000198	0.00145	CbGpPWpGaD
Imipramine—SLC6A4—Circadian rythm related genes—TP53—thymus cancer	0.000169	0.00124	CbGpPWpGaD
Imipramine—HTR7—Circadian rythm related genes—TP53—thymus cancer	0.000159	0.00116	CbGpPWpGaD
Imipramine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000132	0.000963	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MAML2—thymus cancer	0.000124	0.000903	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MAML2—thymus cancer	0.000124	0.000902	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAML2—thymus cancer	0.000117	0.000852	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAML2—thymus cancer	0.000112	0.000816	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAML2—thymus cancer	0.000105	0.000767	CbGpPWpGaD
Imipramine—DRD2—Circadian rythm related genes—TP53—thymus cancer	0.000104	0.000756	CbGpPWpGaD
Imipramine—CHRM1—Circadian rythm related genes—TP53—thymus cancer	0.000101	0.00074	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAML2—thymus cancer	9.16e-05	0.000669	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAML2—thymus cancer	9.12e-05	0.000665	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAML2—thymus cancer	8.73e-05	0.000637	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAML2—thymus cancer	8.05e-05	0.000587	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAML2—thymus cancer	7.92e-05	0.000578	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAML2—thymus cancer	7.9e-05	0.000576	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAML2—thymus cancer	7.87e-05	0.000575	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAML2—thymus cancer	7.85e-05	0.000573	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAML2—thymus cancer	7.77e-05	0.000567	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAML2—thymus cancer	7.75e-05	0.000566	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—IL2—thymus cancer	7.5e-05	0.000547	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—IL2—thymus cancer	7.49e-05	0.000546	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—IL2—thymus cancer	7.07e-05	0.000516	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL2—thymus cancer	6.81e-05	0.000497	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL2—thymus cancer	6.8e-05	0.000496	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—IL2—thymus cancer	6.77e-05	0.000494	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	6.68e-05	0.000488	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL2—thymus cancer	6.42e-05	0.000469	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—IL2—thymus cancer	6.37e-05	0.000465	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL2—thymus cancer	6.15e-05	0.000449	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL2—thymus cancer	5.78e-05	0.000422	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—KIT—thymus cancer	5.71e-05	0.000417	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—KIT—thymus cancer	5.71e-05	0.000417	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	5.64e-05	0.000412	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—IL2—thymus cancer	5.55e-05	0.000405	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—IL2—thymus cancer	5.52e-05	0.000403	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KIT—thymus cancer	5.39e-05	0.000393	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—IL2—thymus cancer	5.28e-05	0.000386	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KIT—thymus cancer	5.16e-05	0.000377	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL2—thymus cancer	5.04e-05	0.000368	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL2—thymus cancer	5.01e-05	0.000366	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—IL2—thymus cancer	4.87e-05	0.000356	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KIT—thymus cancer	4.85e-05	0.000354	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL2—thymus cancer	4.8e-05	0.00035	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—IL2—thymus cancer	4.79e-05	0.00035	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—IL2—thymus cancer	4.78e-05	0.000349	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—IL2—thymus cancer	4.77e-05	0.000348	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—IL2—thymus cancer	4.75e-05	0.000347	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—IL2—thymus cancer	4.71e-05	0.000343	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—IL2—thymus cancer	4.69e-05	0.000343	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL2—thymus cancer	4.42e-05	0.000323	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL2—thymus cancer	4.35e-05	0.000318	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL2—thymus cancer	4.34e-05	0.000317	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL2—thymus cancer	4.33e-05	0.000316	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL2—thymus cancer	4.32e-05	0.000315	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL2—thymus cancer	4.27e-05	0.000312	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL2—thymus cancer	4.26e-05	0.000311	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KIT—thymus cancer	4.23e-05	0.000309	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KIT—thymus cancer	4.21e-05	0.000307	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—AKT1—thymus cancer	4.07e-05	0.000297	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—AKT1—thymus cancer	4.06e-05	0.000296	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KIT—thymus cancer	4.03e-05	0.000294	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL2—thymus cancer	4.02e-05	0.000293	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL2—thymus cancer	4.02e-05	0.000293	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—AKT1—thymus cancer	3.83e-05	0.00028	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL2—thymus cancer	3.79e-05	0.000277	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KIT—thymus cancer	3.71e-05	0.000271	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—AKT1—thymus cancer	3.69e-05	0.000269	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—AKT1—thymus cancer	3.69e-05	0.000269	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—AKT1—thymus cancer	3.67e-05	0.000268	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KIT—thymus cancer	3.65e-05	0.000267	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KIT—thymus cancer	3.65e-05	0.000266	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KIT—thymus cancer	3.64e-05	0.000265	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL2—thymus cancer	3.63e-05	0.000265	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KIT—thymus cancer	3.62e-05	0.000264	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KIT—thymus cancer	3.59e-05	0.000262	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KIT—thymus cancer	3.58e-05	0.000261	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—thymus cancer	3.48e-05	0.000254	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—thymus cancer	3.45e-05	0.000252	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL2—thymus cancer	3.42e-05	0.000249	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—thymus cancer	3.33e-05	0.000243	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—thymus cancer	3.14e-05	0.000229	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—thymus cancer	3.06e-05	0.000223	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—thymus cancer	3.01e-05	0.00022	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—thymus cancer	2.99e-05	0.000218	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL2—thymus cancer	2.98e-05	0.000217	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL2—thymus cancer	2.96e-05	0.000216	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—thymus cancer	2.89e-05	0.000211	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—thymus cancer	2.87e-05	0.000209	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—thymus cancer	2.84e-05	0.000207	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—thymus cancer	2.73e-05	0.000199	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—thymus cancer	2.72e-05	0.000198	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—thymus cancer	2.64e-05	0.000193	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—thymus cancer	2.61e-05	0.000191	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—thymus cancer	2.6e-05	0.00019	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—thymus cancer	2.6e-05	0.00019	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—thymus cancer	2.59e-05	0.000189	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—thymus cancer	2.59e-05	0.000189	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—thymus cancer	2.58e-05	0.000188	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—thymus cancer	2.58e-05	0.000188	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—thymus cancer	2.58e-05	0.000188	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—thymus cancer	2.57e-05	0.000188	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—thymus cancer	2.57e-05	0.000187	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—thymus cancer	2.56e-05	0.000187	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—thymus cancer	2.55e-05	0.000186	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—thymus cancer	2.55e-05	0.000186	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—thymus cancer	2.55e-05	0.000186	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—thymus cancer	2.53e-05	0.000184	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—thymus cancer	2.52e-05	0.000184	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—thymus cancer	2.44e-05	0.000178	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—thymus cancer	2.4e-05	0.000175	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—thymus cancer	2.36e-05	0.000172	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—thymus cancer	2.36e-05	0.000172	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—thymus cancer	2.35e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—thymus cancer	2.34e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—thymus cancer	2.33e-05	0.00017	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—thymus cancer	2.32e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—thymus cancer	2.31e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—thymus cancer	2.19e-05	0.00016	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—thymus cancer	2.18e-05	0.000159	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—thymus cancer	2.18e-05	0.000159	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—thymus cancer	2.06e-05	0.00015	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—thymus cancer	1.97e-05	0.000144	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—thymus cancer	1.92e-05	0.00014	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—thymus cancer	1.92e-05	0.00014	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—thymus cancer	1.91e-05	0.000139	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—thymus cancer	1.9e-05	0.000139	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—thymus cancer	1.85e-05	0.000135	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—thymus cancer	1.82e-05	0.000133	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—thymus cancer	1.79e-05	0.000131	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—thymus cancer	1.68e-05	0.000122	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—thymus cancer	1.65e-05	0.000121	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—thymus cancer	1.65e-05	0.000121	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—thymus cancer	1.65e-05	0.00012	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—thymus cancer	1.64e-05	0.00012	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—thymus cancer	1.64e-05	0.000119	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—thymus cancer	1.62e-05	0.000118	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—thymus cancer	1.62e-05	0.000118	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—thymus cancer	1.61e-05	0.000118	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—thymus cancer	1.61e-05	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—thymus cancer	1.54e-05	0.000112	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—thymus cancer	1.42e-05	0.000104	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—thymus cancer	1.42e-05	0.000103	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—thymus cancer	1.39e-05	0.000102	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—thymus cancer	1.39e-05	0.000102	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—thymus cancer	1.39e-05	0.000102	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—thymus cancer	1.39e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—thymus cancer	1.38e-05	0.000101	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—thymus cancer	1.37e-05	9.99e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—thymus cancer	1.37e-05	9.96e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—thymus cancer	1.07e-05	7.84e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—thymus cancer	1.05e-05	7.66e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—thymus cancer	9.89e-06	7.21e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—thymus cancer	8.38e-06	6.11e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—thymus cancer	6.46e-06	4.72e-05	CbGpPWpGaD
